|
Fluid Imaging Technologies is a global laboratory instrumentation company offering the patented FlowCAM® particle imaging analysis system. The FlowCAM takes hi-res, full color digital images of every particle or cell in a fluid sample and saves them with their data sets for review, analysis and collaboration.
|
|
Parker Life Sciences, a business unit within the Pneutronics Division of Parker Hannifin, brings leading motion control and fluidic control solutions together for life sciences applications. Parker products, sub-systems, and systems are integral to the world's drug discovery, bioanalytical, and medical instrumentation. From miniature solenoid
valves to highly integrated automation systems, Parker Life Sciences develops solutions that help OEM instrument builders speed their products to market faster and lower their overall cost of ownership.
|
| |
Shimadzu Scientific Instruments is the American subsidiary of Shimadzu Corporation, headquartered in Kyoto, Japan. We are a leading provide of analytical instrumentation, including chromatographs, mass spectrometers, spectrophotometers, balances, environmental analyzers, and testing equipment, to serve a broad range of markets and industries.
|
|
Syrris develops and sells productivity tools for R&D chemists. The Atlas flow reactor system offers a modular system for batch synthesis. The FRX flow reactor can work with a few mg of material for method development, or synthesize 1kg per day. Our Dolomite facility fabricates custom microfluidic devices. |
| |
Waters helps laboratory-dependent organizations--from pharmaceutical companies to environmental, food safety or government organizations--make profound discoveries, optimize their operations, deliver product performance, and ensure regulatory compliance by providing breakthrough technologies and solutions. Pioneering a connected portfolio of separation and analytical science, laboratory informatics and mass spectrometry, Waters provides the tools to improve the quality of today's science and explore the infinite possibilities of tomorrow's. |
|
|
|
|
